Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000079 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
21,000
Total Value
$834,122.06
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 36,218 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 39,718 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Sale | 900 | $109.65 | $98,686.98 | 38,818 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Sale | 300 | $110.52 | $33,155.01 | 38,518 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Sale | 3,320 | $112.01 | $371,885.82 | 35,198 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 17, 2026 | Sale | 2,480 | $112.56 | $279,154.26 | 32,718 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 197,063 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Aug 17, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 168,492 | Direct | โ | View Details |